Abstract
Cardiorenal syndromes are disorders of the heart and kidneys whereby acute or long-term dysfunction in one organ may induce acute or long-term dysfunction of the other. The management of cardiovascular diseases and risk factors may influence, in a beneficial or harmful way, kidney function and progression of kidney injury. In this review, we assess therapeutic strategies and discuss treatment options for the management of patients with heart failure with decreased kidney function and highlight the need for future high-quality studies in patients with coexisting heart and kidney disease.
Copyright © 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
MeSH terms
-
Cardiotonic Agents / therapeutic use
-
Cardiovascular Diseases / complications
-
Cardiovascular Diseases / diagnosis
-
Cardiovascular Diseases / mortality
-
Cardiovascular Diseases / therapy*
-
Combined Modality Therapy
-
Disease Progression
-
Diuretics / therapeutic use
-
Drug Therapy, Combination
-
Heart Failure / complications
-
Heart Failure / diagnosis
-
Heart Failure / mortality
-
Heart Failure / therapy*
-
Heart Function Tests
-
Humans
-
Kidney Diseases / complications
-
Kidney Diseases / diagnosis
-
Kidney Diseases / therapy*
-
Kidney Failure, Chronic / complications
-
Kidney Failure, Chronic / diagnosis
-
Kidney Failure, Chronic / mortality
-
Kidney Failure, Chronic / therapy
-
Kidney Function Tests
-
Prognosis
-
Renal Dialysis
-
Risk Assessment
-
Severity of Illness Index
-
Survival Rate
-
Syndrome
-
Vasodilator Agents / therapeutic use
Substances
-
Cardiotonic Agents
-
Diuretics
-
Vasodilator Agents